Close

Integra LifeSciences (IART) Issues Statement Regarding FDA Safety Communication on Acellular Dermal Matrix Products Used in Implant-Based Breast Reconstruction

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/23/2024

1. TSLA
2. SPY
3. GM
4. SPOT
5. AMZN
6. SHW
7. AAPL
8. MINN
9. NVDA
10. IBM


Go back to Integra LifeSciences (IART) Issues Statement Regarding FDA Safety Communication on Acellular Dermal Matrix Products Used in Implant-Based Breast Reconstruction

Integra LifeSciences Statement on the U.S. FDA Safety Communication on Acellular Dermal Matrix (ADM) Products Used in Implant-Based Breast Reconstruction

April 19, 2021 4:15 PM EDT

PRINCETON, N.J., April 19, 2021 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company and manufacturer of... More